Cerebrolysin

Key Benefits#

• Promotes neurogenesis and synaptic plasticity
• Approved for stroke rehabilitation (accelerates recovery)
• Alzheimer's disease: slows progression and improves cognition
• Traumatic brain injury recovery
• Enhances memory and executive function
• Neuroprotection against oxidative stress and excitotoxicity
• Anti-amyloid and anti-tau effects
• Mood improvement and reduced anxiety

Mechanism of Action#

Cerebrolysin is a mixture of low-molecular-weight neuropeptides and amino acids derived from enzymatic digestion of porcine brain proteins. Its active components cross the blood-brain barrier and act as neurotrophic factor mimetics. It activates BDNF, NGF, GDNF, and CNTF receptor pathways to: (1) promote neurogenesis in hippocampus and cortex, (2) reduce amyloid-beta aggregation and tau phosphorylation, (3) protect neurons from apoptosis and oxidative damage, (4) enhance synaptic transmission via AMPA receptor upregulation, and (5) stimulate anti-inflammatory microglial phenotype. Long-term use shows structural brain changes on MRI.

Dosing Protocols#

Side Effects#

• Generally well tolerated
• Mild nausea and dizziness (IV infusion)
• Headache at initiation
• Rare: agitation (usually at very high doses)
• Rare: allergic reaction (porcine origin)
• Rare: seizure risk in epilepsy patients (use with caution)

Contraindications#

Renal failure (avoid). Epilepsy (caution — monitor closely). Pregnancy: insufficient safety data. Avoid rapid IV injection (must infuse slowly). Pork allergy: contraindicated.

Storage#

Store at room temperature (15–25°C). Keep in original ampoules away from light. Do not freeze. Once opened, use immediately (no preservatives).

Featured In Stacks#

1. 1.
   Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort

   Staszewski J, Dębiec A, Gniadek-Olejniczak K, Stępień A, Piusinska-Macoch R, Strilciuc S et al. · Translational stroke research · 2026PubMed Verified

2. 2.
   Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: post hoc secondary analysis of the CEREHETIS trial

   Kalinin MN, Khasanova DR · Frontiers in pharmacology · 2025PubMed Verified

3. 3.
   Surgical excision of cerebral glioma and multimodal treatment including Cerebrolysin: a case report

   González JDSR, Tapia A · Journal of medicine and life · 2025Case ReportPubMed Verified

4. 4.
   Use of nootropics in Alzheimer's disease: An analysis of regulatory positions and drug policies in the countries of the Commonwealth of Independent States

   Alexandrova EG, Abakumova TR, Ziganshina LE · The International journal of risk & safety in medicine · 2025PubMed Verified

5. 5.
   Cerebrolysin Ameliorates Age-Induced Dendritic Spine Degeneration and Memory Decline in C57BL6 Mice

   Aguilar-Hernández L, Flores-Gómez GD, Nacher J, Morales-Medina JC, Flores G · Neurochemical research · 2025PubMed Verified

6. 6.
   Combined citicoline and Cerebrolysin for neuroprotection in traumatic brain injury: a retrospective cohort analysis

   Schlager P, Grgac I, Herzer G, Trimmel H · Frontiers in neurology · 2025PubMed Verified

7. 7.
   Delta power surge and alpha power decline in traumatic brain injury recovery: A quantitative EEG analysis of the CAPTAIN-rTMS trial

   Livinț-Popa L, Chelaru VF, Chertic-Dăbală D, Chira D, Verișezan-Roșu O, Dăbală V et al. · Journal of clinical and translational science · 2025PubMed Verified

8. 8.
   Retraction Note: Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure

   Rockenstein E, Ubhi K, Trejo M, Mante M, Patrick C, Adame A et al. · BMC neuroscience · 2025PubMed Verified

9. 9.
   Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy

   Ribó M, Staszewski J, Zeiler SR, Michalak S, El Bassiouny A, Gongora-Rivera F et al. · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2026ReviewPubMed Verified

10. 10.
    Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway

    Hosseini L, Abolhasanpour N, Seyedaghamiri F, Hassanzadeh P, Shahabi P, Mafikandi V et al. · Molecular brain · 2025PubMed Verified

11. 11.
    Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis

    Masserini F, Gendarini C, Baso G, Salvadori E, Pantoni L · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Meta-AnalysisPubMed Verified

12. 12.
    Safety and feasibility of cerebrolysin in treatment of primary intracerebral hemorrhage (CLINCH)-a prospective, randomized, open-label, blinded endpoint pilot trial

    Kobayashi A, Rutkowska K, Gocyla-Dudar K, Chelstowska B, Pozarowszczyk N, Karlinski M · Frontiers in neurology · 2025PubMed Verified

13. 13.
    Cerebrolysin treatment in a case of post-herpes simplex encephalitis with neuropsychiatric symptoms

    Lee YS, Seo J, Yim SH · Journal of medicine and life · 2025Case ReportPubMed Verified

14. 14.
    Left atrial occlusion in intracerebral hemorrhage with atrial fibrillation, herpes zoster, and stroke, improving stroke outcomes in China, and Cerebrolysin as a treatment for acute stroke

    Markus HS · International journal of stroke : official journal of the International Stroke Society · 2025PubMed Verified

15. 15.
    Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 14 Randomized Controlled Trials

    Patel PN, Mangal D, Patel K · Cureus · 2025ReviewPubMed Verified

16. 16.
    Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study

    Kandasamy G, Arumugam V, Orayj K, Alshahrani AM, Alanazi TS, Hmlan A et al. · Medicina (Kaunas, Lithuania) · 2025PubMed Verified

17. 17.
    Microglial Polarization and Therapeutic Strategies in Post-stroke Neuroinflammation

    Chan TYH, Ma BY, Hung TK, Wong JSY, Lo BWY · Neurology and therapy · 2025ReviewPubMed Verified

18. 18.
    C-REGS2-A multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke

    Vosko MR, Sanak D, Do Y, Vatanagul JS, Roushdy T, Bornstein NM et al. · International journal of stroke : official journal of the International Stroke Society · 2025PubMed Verified

19. 19.
    Neuroprotective Agents With Reperfusion Therapies in Ischemic Stroke: Evidence From Recent Randomized Trials

    Wesley MJ, Gundala Raja H, Shahid MS, Akbar A, Jeyakumar D, Veluchamy E et al. · Cureus · 2025ReviewPubMed Verified

20. 20.
    Is Cerebrolysin Useful in Psychiatry Disorders?

    Florek S, Główczyński P, Badura-Brzoza K, Pudlo R · Biomedicines · 2025PubMed Verified

21. 21.
    Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in the prefrontal cortex of male mice in the ketamine model of schizophrenia

    Mafikandi V, Hosseini L, Seyedaghamiri F, Mansourian H, Shahabi P, Taghizadeh S et al. · Molecular biology reports · 2025PubMed Verified

22. 22.
    Cerebrolysin-loaded platelet-rich plasma exosomes: Restoring immune homeostasis via TNF-α/IL-10 modulation and apoptosis targeting for spinal cord injury repair

    Akbari-Gharalari N, Aliyari-Serej Z, Ghahremani-Nasab M, Zangbar HS, Yahyavi Y, Nezhadshahmohammad F et al. · The journal of spinal cord medicine · 2026PubMed Verified

23. 23.
    Cost-effectiveness of Cerebrolysin as an add-on treatment for neurorecovery after traumatic brain injury

    Strilciuc S, Grad DA, Vlădescu C, Buzoianu AD, Albu C, Mureșanu DF · Journal of medicine and life · 2025PubMed Verified

24. 24.
    Influence of Exogenous Neuropeptides on the Astrocyte Response Under Conditions of Continuous and Cyclic Hypoxia and Red Blood Cell Lysate

    Kojder K, Gąssowska-Dobrowolska M, Żwierełło W, Kłos P, Piotrowska K, Wszołek A et al. · International journal of molecular sciences · 2025PubMed Verified

25. 25.
    Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass Graft Patients

    Stadnik A, Jezierska M, Płotek W, Siwicka D, Mlak R, Dąbrowski W · Medical science monitor : international medical journal of experimental and clinical research · 2025PubMed Verified

26. 26.
    Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study

    Staszewski J, Dębiec A, Strilciuc S, Gniadek-Olejniczak K, Piusinska-Macoch R, Balo D et al. · Translational stroke research · 2025Clinical TrialPubMed Verified

27. 27.
    Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay

    Kurkin DV, Bakulin DA, Morkovin EI, Petrov VI, Strygin AV, Smirnov AV et al. · Biomedicines · 2025PubMed Verified

28. 28.
    Conservative and newer drug treatment for degenerative cervical myelopathy

    Ede O, Cheung JPY · Journal of clinical orthopaedics and trauma · 2025PubMed Verified

29. 29.
    Cerebrolysin Induces Dendritic Tree Plastic Changes and BDNF Increase in the Amygdala of Male Rats with Maternal Deprivation

    Cárdenas-Bedoya J, Torres-Mendoza BM, Martínez-Torres NI · Neurochemical research · 2025PubMed Verified

30. 30.
    Update on Neuroprotection after Traumatic Brain Injury

    Cook AM, Michas M, Robbins B · CNS drugs · 2025ReviewPubMed Verified

31. 31.
    Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies

    Rockenstein E, Ubhi K, Mante M, Florio J, Adame A, Winter S et al. · BMC neuroscience · 2025PubMed Verified

32. 32.
    Cerebrolysin as an adjuvant therapy after mechanical thrombectomy in large vessel occlusion cardioembolic stroke: a propensity score matching analysis

    ElBassiouny A, Shehata MSA, Zaki AS, Bedros RY, El-Sudany AH, Nasser AA · Frontiers in neurology · 2025PubMed Verified

33. 33.
    Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study

    Homberg V, Jianu DC, Stan A, Strilciuc Ș, Chelaru VF, Karliński M et al. · Stroke · 2025RCTPubMed Verified

34. 34.
    Correction to: Sonic Hedgehog Signaling Pathway Mediates Cerebrolysin-Improved Neurological Function After Stroke

    Stroke · 2025PubMed Verified

35. 35.
    Importance of Modulating Kynurenic Acid Metabolism-Approaches for the Treatment of Dementia

    Baran H, Jan Pietryja M, Kepplinger B · Biomolecules · 2025ReviewPubMed Verified

36. 36.
    Comparative efficacy of neuroprotective agents for improving neurological function and prognosis in acute ischemic stroke: a network meta-analysis

    Wang Y, Li M, Jiang Y, Ji Q · Frontiers in neuroscience · 2024Meta-AnalysisPubMed Verified

37. 37.
    The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts

    Al-Kuraishy HM, Al-Gareeb AI, Zekry SH, Alruwaili M, Alexiou A, Papadakis M et al. · Neuroscience · 2025ReviewPubMed Verified

38. 38.
    Cerebrolysin treatment improved short-term memory deficits while simultaneously increasing hippocampal spine density in hypertensive female rats

    Espinoza I, Gómez-Villalobos MJ, Aguilar-Hernández L, Flores G, Morales-Medina JC · Behavioural brain research · 2025PubMed Verified

39. 39.
    Retraction Note to: Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer's Disease

    Sharma HS, Muresanu DF, Lafuente JV, Patnaik R, Tian ZR, Ozkizilcik A et al. · Molecular neurobiology · 2025PubMed Verified

40. 40.
    Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage-The Results of an Observational Cohort Study

    Kojder K, Jarosz K, Andrzejewska A, Solek-Pastuszka J, Skonieczna-Żydecka K, Kaczmarczyk M et al. · Biomedicines · 2024PubMed Verified

41. 41.
    The effectiveness of olfactory training for chronic olfactory disorder following COVID-19: a systematic review

    Treder-Rochna N, Mańkowska A, Kujawa W, Harciarek M · Frontiers in human neuroscience · 2024Meta-AnalysisPubMed Verified

42. 42.
    Cerebrolysin Induces Motor Recovery Along with Plastic Changes in Motoneurons and an Increase in GAP43 Protein in the Ventral Spinal Cord Following a Kainic Acid Excitotoxic Lesion in the Rat Motor Cortex

    Martínez-Torres NI, Cárdenas-Bedoya J, Torres-Mendoza BM · Neurochemical research · 2024PubMed Verified

43. 43.
    Efficacy analysis of neuroprotective drugs in patients with acute ischemic stroke based on network meta-analysis

    Li M, Huo X, Chang Q, Liu X, Zhang J, Mao Z · Frontiers in pharmacology · 2024Meta-AnalysisPubMed Verified

44. 44.
    Evaluating the Effectiveness of Neuroprotective Strategies in Enhancing Post-stroke Recovery: A Systematic Review of Meta-Analyses and Clinical Trials

    Hassan BD, Dabas MM, Kanemitsu K, Faran N, Abbas T · Cureus · 2024ReviewPubMed Verified

45. 45.
    Treatment of COVID-19 Associated Olfactory Dysfunction: A Systematic Review

    Bischoff S, Moyaert M, Clijsters M, Vanderbroek A, Van Gerven L · Current allergy and asthma reports · 2024Meta-AnalysisPubMed Verified

46. 46.
    Challenged papers underpin several drugs

    Piller C · Science (New York, N.Y.) · 2024PubMed Verified

47. 47.
    Evidence-Based Review of Randomized Controlled Trials of Interventions for Mental Health Management Post-Moderate to Severe Traumatic Brain Injury

    Flores-Sandoval C, Teasell R, MacKenzie HM, McIntyre A, Barua U, Mehta S et al. · The Journal of head trauma rehabilitation · 2024Meta-AnalysisPubMed Verified

48. 48.
    Cerebrolysin Concentrate: Therapeutic Potential for Severe Oral Apraxia After Stroke: A Case Report

    Jeon H, Kim DY · Brain & NeuroRehabilitation · 2024Case ReportPubMed Verified

49. 49.
    Life-Threatening Anaphylaxis due to Cerebrolysin®

    Trimmel H, Tauber W, Zikeli M · Case reports in neurological medicine · 2024Case ReportPubMed Verified

50. 50.
    QEEG indices in traumatic brain injury - insights from the CAPTAIN RTMS trial

    Olivia VR, Chira D, Chelaru VF, Diana CD, Livia LP, Buruiană AM et al. · Journal of medicine and life · 2024PubMed Verified